ALDH7A1 and chronic obstructive pulmonary disease: Current COPD treatments, macrolides and PDE inhibitors may exert anti-inflammatory (and for macrolides antimicrobial) effects that lessen the amplitude of neutrophil-related inflammatory processes in the COPD airways.